UNC0379 (TFA)


CAS No. : 1620401-83-3

1620401-83-3
Price and Availability of CAS No. : 1620401-83-3
Size Price Stock
2mg $80 In-stock
5mg $120 In-stock
10 mg Get quote
50 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-12335A
M.Wt: 527.58
Formula: C25H36F3N5O4
Purity: >98 %
Solubility: H2O : 100 mg/mL (ultrasonic)
Introduction of 1620401-83-3 :

UNC0379 TFA is a selective, substrate-competitive inhibitor of lysine methyltransferase SETD8 (KMT5A) with an IC50 of 7.3 μM, KD value of 18.3 μM. UNC0379 TFA can be used in the research of inflammation and cancers, such as pulmonary fibrosis, ovarian cancer, neuroblastoma[1][2][3]. IC50 & Target: SETD8 (KMT5A)[1] In Vitro: UNC0379 TFA (1-10 μM, 9 days) inhibits HGSOC cells proliferation[2].
UNC0379 TFA (10 μM, 96 h) increases in the proportion of sub-G1 phase cells in HGSOC cells[2].
UNC0379 TFA (10 μM, 48 h) induces myofibroblast de-differentiation and inhibits additional fibroblast to myofibroblast differentiation[3].
In Vivo: UNC0379 TFA (intratracheal administration, 1 mg/kg/day, 1 mg/kg/day, on day7, 8, and 9) ameliorates the lung fibrosis in Bleomycin (BLM)-induced lung fibrosis mouse[3].

Your information is safe with us.